Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data

By: TheNewswire.com

March 02, 2023 at 05:59 AM EST

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.

Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

More News

D-Wave: Time to Buy the Dip? Or is the Fall Just Starting? ↗

Today 18:55 EST

Via MarketBeat

Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗

Today 17:32 EST

Via MarketBeat

Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3 ↗

Today 16:45 EST

Via MarketBeat

JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook ↗

Today 16:15 EST

Via MarketBeat

Why Circle Stock Is Falling—and Why Some Analysts See Big Upside ↗

Today 15:33 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	226.28	+5.59 (2.53%)
AAPL	275.92	+4.43 (1.63%)
AMD	215.05	+11.27 (5.53%)
BAC	51.93	+0.37 (0.72%)
GOOG	318.47	+18.82 (6.28%)
META	613.05	+18.80 (3.16%)
MSFT	474.00	+1.88 (0.40%)
NVDA	182.55	+3.67 (2.05%)
ORCL	200.28	+1.52 (0.76%)
TSLA	417.78	+26.69 (6.82%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.